The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global S-Amlodipine Market Research Report 2025

Global S-Amlodipine Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1739793

No of Pages : 107

Ask Your Query

Synopsis
S AMLODIPINE belongs to a class of medicines called calcium channel blockers which are primarily taken to treat hypertension (high blood pressure) and angina (chest pain).

Global S-Amlodipine market is projected to reach US$ 75320 million in 2029, increasing from US$ 35600 million in 2022, with the CAGR of 11.3% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole S-Amlodipine market research.

Hypertension is a common cardiovascular disease affecting a large proportion of the global population. The increasing prevalence of hypertension worldwide is driving the demand for effective antihypertensive drugs such as S-amlodipine.

Report Scope

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global S-Amlodipine market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

By Company

  • Aristo Pharmaceuticals Pvt Ltd
  • Novartis
  • Pfizer
  • Lek
  • TEVA
  • Macleods Pharmaceuticals
  • Caraco Pharmaceutical
  • Sanis Health
  • Jamp Pharma
  • Accel Pharma
  • Jubilant Generics
  • Angita Pharma
  • Florida DOH Central Pharmacy
  • Chengdu Di'ao Pharmaceutical Group Co., Ltd.
  • Yangzijiang Pharmaceutical

Segment by Type

  • Amlodipine Besylate Tablets
  • Amlodipine Mesylate Tablets
  • Amlodipine Maleate Tablets

Segment by Application

  • Hypertension
  • Angina pectoris

Consumption by Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
  • Latin America (Mexico, Brazil, Argentina)
  • Middle East & Africa (Turkey, Saudi Arabia, UAE)

The S-Amlodipine report covers below items:

Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source

Index

1 S-Amlodipine Market Overview
1.1 Product Overview and Scope of S-Amlodipine
1.2 S-Amlodipine Segment by Type
1.2.1 Global S-Amlodipine Market Value Comparison by Type (2023-2029)
1.2.2 Amlodipine Besylate Tablets
1.2.3 Amlodipine Mesylate Tablets
1.2.4 Amlodipine Maleate Tablets
1.3 S-Amlodipine Segment by Application
1.3.1 Global S-Amlodipine Market Value by Application: (2023-2029)
1.3.2 Hypertension
1.3.3 Angina pectoris
1.4 Global S-Amlodipine Market Size Estimates and Forecasts
1.4.1 Global S-Amlodipine Revenue 2018-2029
1.4.2 Global S-Amlodipine Sales 2018-2029
1.4.3 Global S-Amlodipine Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 S-Amlodipine Market Competition by Manufacturers
2.1 Global S-Amlodipine Sales Market Share by Manufacturers (2018-2023)
2.2 Global S-Amlodipine Revenue Market Share by Manufacturers (2018-2023)
2.3 Global S-Amlodipine Average Price by Manufacturers (2018-2023)
2.4 Global S-Amlodipine Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of S-Amlodipine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of S-Amlodipine, Product Type & Application
2.7 S-Amlodipine Market Competitive Situation and Trends
2.7.1 S-Amlodipine Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest S-Amlodipine Players Market Share by Revenue
2.7.3 Global S-Amlodipine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 S-Amlodipine Retrospective Market Scenario by Region
3.1 Global S-Amlodipine Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global S-Amlodipine Global S-Amlodipine Sales by Region: 2018-2029
3.2.1 Global S-Amlodipine Sales by Region: 2018-2023
3.2.2 Global S-Amlodipine Sales by Region: 2024-2029
3.3 Global S-Amlodipine Global S-Amlodipine Revenue by Region: 2018-2029
3.3.1 Global S-Amlodipine Revenue by Region: 2018-2023
3.3.2 Global S-Amlodipine Revenue by Region: 2024-2029
3.4 North America S-Amlodipine Market Facts & Figures by Country
3.4.1 North America S-Amlodipine Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America S-Amlodipine Sales by Country (2018-2029)
3.4.3 North America S-Amlodipine Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe S-Amlodipine Market Facts & Figures by Country
3.5.1 Europe S-Amlodipine Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe S-Amlodipine Sales by Country (2018-2029)
3.5.3 Europe S-Amlodipine Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific S-Amlodipine Market Facts & Figures by Country
3.6.1 Asia Pacific S-Amlodipine Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific S-Amlodipine Sales by Country (2018-2029)
3.6.3 Asia Pacific S-Amlodipine Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America S-Amlodipine Market Facts & Figures by Country
3.7.1 Latin America S-Amlodipine Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America S-Amlodipine Sales by Country (2018-2029)
3.7.3 Latin America S-Amlodipine Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa S-Amlodipine Market Facts & Figures by Country
3.8.1 Middle East and Africa S-Amlodipine Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa S-Amlodipine Sales by Country (2018-2029)
3.8.3 Middle East and Africa S-Amlodipine Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global S-Amlodipine Sales by Type (2018-2029)
4.1.1 Global S-Amlodipine Sales by Type (2018-2023)
4.1.2 Global S-Amlodipine Sales by Type (2024-2029)
4.1.3 Global S-Amlodipine Sales Market Share by Type (2018-2029)
4.2 Global S-Amlodipine Revenue by Type (2018-2029)
4.2.1 Global S-Amlodipine Revenue by Type (2018-2023)
4.2.2 Global S-Amlodipine Revenue by Type (2024-2029)
4.2.3 Global S-Amlodipine Revenue Market Share by Type (2018-2029)
4.3 Global S-Amlodipine Price by Type (2018-2029)
5 Segment by Application
5.1 Global S-Amlodipine Sales by Application (2018-2029)
5.1.1 Global S-Amlodipine Sales by Application (2018-2023)
5.1.2 Global S-Amlodipine Sales by Application (2024-2029)
5.1.3 Global S-Amlodipine Sales Market Share by Application (2018-2029)
5.2 Global S-Amlodipine Revenue by Application (2018-2029)
5.2.1 Global S-Amlodipine Revenue by Application (2018-2023)
5.2.2 Global S-Amlodipine Revenue by Application (2024-2029)
5.2.3 Global S-Amlodipine Revenue Market Share by Application (2018-2029)
5.3 Global S-Amlodipine Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Aristo Pharmaceuticals Pvt Ltd
6.1.1 Aristo Pharmaceuticals Pvt Ltd Corporation Information
6.1.2 Aristo Pharmaceuticals Pvt Ltd Description and Business Overview
6.1.3 Aristo Pharmaceuticals Pvt Ltd S-Amlodipine Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Aristo Pharmaceuticals Pvt Ltd S-Amlodipine Product Portfolio
6.1.5 Aristo Pharmaceuticals Pvt Ltd Recent Developments/Updates
6.2 Novartis
6.2.1 Novartis Corporation Information
6.2.2 Novartis Description and Business Overview
6.2.3 Novartis S-Amlodipine Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Novartis S-Amlodipine Product Portfolio
6.2.5 Novartis Recent Developments/Updates
6.3 Pfizer
6.3.1 Pfizer Corporation Information
6.3.2 Pfizer Description and Business Overview
6.3.3 Pfizer S-Amlodipine Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Pfizer S-Amlodipine Product Portfolio
6.3.5 Pfizer Recent Developments/Updates
6.4 Lek
6.4.1 Lek Corporation Information
6.4.2 Lek Description and Business Overview
6.4.3 Lek S-Amlodipine Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Lek S-Amlodipine Product Portfolio
6.4.5 Lek Recent Developments/Updates
6.5 TEVA
6.5.1 TEVA Corporation Information
6.5.2 TEVA Description and Business Overview
6.5.3 TEVA S-Amlodipine Sales, Revenue and Gross Margin (2018-2023)
6.5.4 TEVA S-Amlodipine Product Portfolio
6.5.5 TEVA Recent Developments/Updates
6.6 Macleods Pharmaceuticals
6.6.1 Macleods Pharmaceuticals Corporation Information
6.6.2 Macleods Pharmaceuticals Description and Business Overview
6.6.3 Macleods Pharmaceuticals S-Amlodipine Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Macleods Pharmaceuticals S-Amlodipine Product Portfolio
6.6.5 Macleods Pharmaceuticals Recent Developments/Updates
6.7 Caraco Pharmaceutical
6.6.1 Caraco Pharmaceutical Corporation Information
6.6.2 Caraco Pharmaceutical Description and Business Overview
6.6.3 Caraco Pharmaceutical S-Amlodipine Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Caraco Pharmaceutical S-Amlodipine Product Portfolio
6.7.5 Caraco Pharmaceutical Recent Developments/Updates
6.8 Sanis Health
6.8.1 Sanis Health Corporation Information
6.8.2 Sanis Health Description and Business Overview
6.8.3 Sanis Health S-Amlodipine Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Sanis Health S-Amlodipine Product Portfolio
6.8.5 Sanis Health Recent Developments/Updates
6.9 Jamp Pharma
6.9.1 Jamp Pharma Corporation Information
6.9.2 Jamp Pharma Description and Business Overview
6.9.3 Jamp Pharma S-Amlodipine Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Jamp Pharma S-Amlodipine Product Portfolio
6.9.5 Jamp Pharma Recent Developments/Updates
6.10 Accel Pharma
6.10.1 Accel Pharma Corporation Information
6.10.2 Accel Pharma Description and Business Overview
6.10.3 Accel Pharma S-Amlodipine Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Accel Pharma S-Amlodipine Product Portfolio
6.10.5 Accel Pharma Recent Developments/Updates
6.11 Jubilant Generics
6.11.1 Jubilant Generics Corporation Information
6.11.2 Jubilant Generics S-Amlodipine Description and Business Overview
6.11.3 Jubilant Generics S-Amlodipine Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Jubilant Generics S-Amlodipine Product Portfolio
6.11.5 Jubilant Generics Recent Developments/Updates
6.12 Angita Pharma
6.12.1 Angita Pharma Corporation Information
6.12.2 Angita Pharma S-Amlodipine Description and Business Overview
6.12.3 Angita Pharma S-Amlodipine Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Angita Pharma S-Amlodipine Product Portfolio
6.12.5 Angita Pharma Recent Developments/Updates
6.13 Florida DOH Central Pharmacy
6.13.1 Florida DOH Central Pharmacy Corporation Information
6.13.2 Florida DOH Central Pharmacy S-Amlodipine Description and Business Overview
6.13.3 Florida DOH Central Pharmacy S-Amlodipine Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Florida DOH Central Pharmacy S-Amlodipine Product Portfolio
6.13.5 Florida DOH Central Pharmacy Recent Developments/Updates
6.14 Chengdu Di'ao Pharmaceutical Group Co., Ltd.
6.14.1 Chengdu Di'ao Pharmaceutical Group Co., Ltd. Corporation Information
6.14.2 Chengdu Di'ao Pharmaceutical Group Co., Ltd. S-Amlodipine Description and Business Overview
6.14.3 Chengdu Di'ao Pharmaceutical Group Co., Ltd. S-Amlodipine Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Chengdu Di'ao Pharmaceutical Group Co., Ltd. S-Amlodipine Product Portfolio
6.14.5 Chengdu Di'ao Pharmaceutical Group Co., Ltd. Recent Developments/Updates
6.15 Yangzijiang Pharmaceutical
6.15.1 Yangzijiang Pharmaceutical Corporation Information
6.15.2 Yangzijiang Pharmaceutical S-Amlodipine Description and Business Overview
6.15.3 Yangzijiang Pharmaceutical S-Amlodipine Sales, Revenue and Gross Margin (2018-2023)
6.15.4 Yangzijiang Pharmaceutical S-Amlodipine Product Portfolio
6.15.5 Yangzijiang Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 S-Amlodipine Industry Chain Analysis
7.2 S-Amlodipine Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 S-Amlodipine Production Mode & Process
7.4 S-Amlodipine Sales and Marketing
7.4.1 S-Amlodipine Sales Channels
7.4.2 S-Amlodipine Distributors
7.5 S-Amlodipine Customers
8 S-Amlodipine Market Dynamics
8.1 S-Amlodipine Industry Trends
8.2 S-Amlodipine Market Drivers
8.3 S-Amlodipine Market Challenges
8.4 S-Amlodipine Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock